Transparency Market Research
U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research
Buy Now Request Sample
Published Date: June 2013
Single User License: US $ 4595 Multi User License: US $ 7595
82 Pages Report
Corporate User License: US $ 10595
REPORT DESCRIPTION U.S. Vaccine Market - Industry Analysis, Size, Share, Growth, And Forecast 2012 2018 The U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market. U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market. Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization. Adult & adolescent vaccine market is expected to grow moderately over the next six years due to rising awareness and increasing vaccination for human papillomavirus (HPV) and such other viral diseases.
Browse Report : U.S. human vaccine market Livestock vaccine is the leading segment of the overall U.S. animal vaccine market accounting for 58.1% in 2012 due to more organized dairy sector and increased awareness towards prevention of infectious diseases in cattle. Bovine vaccine market is the largest revenue generating segment of the overall Livestock vaccine market in 2012 due to rising vaccination to protect breeding animals against infectious diseases. Together feline vaccine and canine vaccine accounted for about 95.1% of the overall U.S. companion animal vaccine market in 2011. In 2011, overall leading producers of human vaccine for the U.S. market were SanofiAventis, Merck, GlaxoSmithKline, Pfizer, Sanofi-Pasture and Novartis. The leading producers of animal vaccine for the U.S. market includes Pfizer Animal Health, Merial (Sanofi-Aventis), Intervet/Schering-Plough (Merck) and Novartis Animal Health. This report helps to identify factors, which will be the driving force behind the U.S. Vaccine market and sub-markets in the next six years. The report provides extensive analysis of the U.S. vaccine market, current market trends, industry drivers and challenges for better understanding of the U.S. vaccine market structure. The report has segregated the U.S. vaccine industry in terms of its product type. Annual estimates and forecasts are provided for the period 2012 through 2018 in terms of value in USD million. Segments Analyzed U.S. vaccine market- by Product
Human vaccine
Pediatric Vaccines
Adult & Adolescent vaccine
Other human vaccine
Animal vaccine
Livestock vaccine
Bovine vaccine
Porcine vaccine
Ovine vaccine
Companion animal vaccine
Feline vaccine
Canine vaccine
Equine vaccine
Other animal vaccine
Browse the database at http://www.transparencymarketresearch.com/usvaccine-market.html
TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1.1 REPORT DESCRIPTION 1.2 METHODOLOGY
CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 U.S. VACCINE MARKET, 2012 - 2018 3.1 MARKET OVERVIEW 3.2 VACCINE MARKET CHARACTERISTICS 3.3 LAWS AND REGULATIONS 3.3.1 VACCINE APPROVAL PROCESS 3.4 U.S. VACCINE MARKET ESTIMATE AND FORECAST, 2012 - 2018 3.4.1 MARKET SHARE BY VACCINE TYPE 3.5 LIST OF COMPANIES SUPPLYING VACCINES IN THE U.S. 3.6 VACCINE PRICING 3.6.1 PRICES FOR VACCINES CONTAINING THIMEROSAL AS A PRESERVATIVE 3.6.2 PRICES OF VACCINES FREE OF PRESERVATIVES: 3.7 MARKET DYNAMICS 3.7.1 DRIVERS 3.7.1.1 Rise in incidences of viral infection driving the growth of vaccine market in the U.S. 3.7.1.2 Biotechnology research enabling synthesis of new vaccines to target complex human diseases driving the vaccine market 3.7.1.3 Government recommendation for adult and adolescent immunization will boost the growth of Vaccine market in U.S.
3.7.1.4 Rise in infectious diseases in animals driving the market 3.7.2 RESTRAINTS 3.7.2.1 Cost of refrigeration 3.7.2.2 Short functional shelf life of certain vaccines will have negative impact on the market growth 3.7.3 OPPORTUNITIES 3.7.3.1 Huge product pipeline of the multinational firms will act as an opportunity for future growth 3.8 IMPACT ANALYSIS OF DRIVERS 3.9 IMPACT ANALYSIS OF RESTRAINTS 3.10 PORTER’S FIVE FORCE ANALYSIS 3.10.1 BARGAINING POWER OF SUPPLIER 3.10.2 BARGAINING POWER OF BUYER 3.10.3 RIVALRY AMONG EXISTING COMPETITORS 3.10.4 THREAT OF NEW ENTRANTS 3.10.5 THREAT OF SUBSTITUTE
CHAPTER 4 U.S. VACCINE MARKET BY PRODUCT TYPE 4.1 HUMAN VACCINE 4.1.1 MARKET ANALYSIS, SIZE AND FORECAST 4.1.2 MARKET ATTRACTIVENESS ANALYSIS FOR HUMAN VACCINE MARKET 4.1.3 PEDIATRIC VACCINES 4.1.3.1 Market Analysis, Size and Forecast 4.1.3.2 Pediatric vaccine price list 4.1.3.3 Pediatric Influenza Vaccine price list 4.1.3.4 HaemophilusInfluenzae Type B 4.1.3.4.1 Hib Pricing 4.1.3.5 Hepatitis A
Browse the database at http://www.transparencymarketresearch.com/usvaccine-market.html
4.1.3.5.1 HAV Pricing 4.1.3.6 Hepatitis B 4.1.3.6.1 Hepatitis B Pricing 4.1.4 ADULT & ADOLESCENT VACCINES 4.1.4.1 Market Analysis, Size and Forecast 4.1.4.2 Adult vaccine price list 4.1.4.3 Adult Influenza Vaccine price list 4.1.5 OTHER HUMAN VACCINES 4.1.5.1 Market Analysis, Size and Forecast 4.2 ANIMAL VACCINE 4.2.1 MARKET ANALYSIS, SIZE AND FORECAST 4.2.2 MARKET ATTRACTIVENESS ANALYSIS FOR ANIMAL VACCINE 4.2.3 LIVESTOCK VACCINES 4.2.3.1 Market Analysis, Size and Forecast 4.2.3.2 Bovine Vaccines 4.2.3.2.1 Market Analysis, Size and Forecast 4.2.3.3 Porcine Vaccines 4.2.3.3.1 Market Analysis, Size and Forecast 4.2.3.4 Ovine Vaccines 4.2.3.4.1 Market Analysis, Size and Forecast 4.2.4 COMPANION ANIMAL VACCINES 4.2.4.1 Market Analysis, Size and Forecast 4.2.4.2 Feline Vaccines 4.2.4.2.1 Market Analysis, Size and Forecast
4.2.4.3 Canine Vaccines 4.2.4.3.1 Market Analysis, Size and Forecast 4.2.4.4 Equine Vaccines 4.2.4.4.1 Market Analysis, Size and Forecast 4.2.5 OTHER ANIMAL VACCINES 4.2.5.1 Market Analysis, Size and Forecast
CHAPTER 5 COMPETITIVE LANDSCAPE 5.1 MARKET SHARE ANALYSIS 5.2 COMPETITIVE ANALYSIS FOR KEY MARKET PLAYERS
CHAPTER 6 COMPANY PROFILE 6.1 SANOFI-AVENTIS 6.1.1 COMPANY OVERVIEW 6.1.2 FINANCIAL OVERVIEW 6.1.3 SWOT ANALYSIS 6.1.1 RECENT DEVELOPMENT 6.2 GLAXOSMITHKLINE 6.2.1 COMPANY OVERVIEW 6.2.2 FINANCIAL OVERVIEW: 6.2.3 SEGMENT OVERVIEW 6.2.4 SWOT ANALYSIS 6.2.5 RECENT DEVELOPMENTS 6.3 MERCK & COMPANY INCORPORATED 6.3.1 COMPANY OVERVIEW 6.3.2 FINANCIAL OVERVIEW: 6.3.1 RECENT DEVELOPMENT
Browse the database at http://www.transparencymarketresearch.com/usvaccine-market.html
6.4 PFIZER INCORPORATED 6.4.1 COMPANY OVERVIEW 6.4.2 FINANCIAL OVERVIEW 6.4.3 RECENT DEVELOPMENT 6.5 ASTRAZENECA PLC 6.5.1 COMPANY OVERVIEW 6.5.2 FINANCIAL OVERVIEW: 6.5.3 RECENT DEVELOPMENT 6.6 NOVARTIS AG 6.6.1 COMPANY OVERVIEW 6.6.2 FINANCIAL OVERVIEW: 6.6.3 SWOT ANALYSIS 6.6.1 RECENT DEVELOPMENT 6.7 BOEHRINGER 6.7.1 COMPANY OVERVIEW 6.7.2 NET SALES BY BUSINESS 6.7.3 SWOT ANALYSIS 6.7.4 RECENT DEVELOPMENT
About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/